- Home
- EDRY vs LONA Comparison
EDRY vs LONA Comparison
Compare EDRY & LONA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$19.95
N/A
Current Price
$6.50
Company Overview
Basic Information| Metric | EDRY | LONA |
|---|---|---|
| Founded | 2018 | 2011 |
| Country | Greece | United States |
| Employees | N/A | 26 |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.3M | 53.4M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | EDRY | LONA |
|---|---|---|
| Price | $19.95 | $6.50 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 27.1K | ★ 52.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $27.85 | N/A |
| Revenue Next Year | $10.51 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.64 | $4.21 |
| 52 Week High | $23.98 | $6.61 |
Technical Indicators
Market Signals| Indicator | EDRY | LONA |
|---|---|---|
| Relative Strength Index (RSI) | 58.75 | 61.24 |
| Support Level | $11.73 | $4.34 |
| Resistance Level | $23.98 | N/A |
| Average True Range (ATR) | 1.74 | 0.51 |
| MACD | -0.17 | 0.11 |
| Stochastic Oscillator | 44.80 | 84.70 |
Price Performance
Historical Comparison EDRY
LONA
About EDRY EuroDry Ltd.
EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulk such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers. It operates under one operating and one reportable segment, that of operating dry bulk vessels.
About LONA LeonaBio Inc. Common Stock
LeonaBio Inc is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS).